Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C
CONCLUSIONS Activated neutrophils expressing IL-1β can be targeted by IVIG, supporting its use in both KD and MIS-C to ameliorate inflammation.FUNDING Patient Centered Outcomes Research Institute; NIH; American Asthma Foundation; American Heart Association; Novo Nordisk Foundation; NIGMS; American Academy of Allergy, Asthma and Immunology Foundation.
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Yanfang P. Zhu, Isaac Shamie, Jamie C. Lee, Cameron J. Nowell, Weiqi Peng, Shiela Angulo, Linh N.N. Le, Yushan Liu, Huilai Miao, Hainan Xiong, Cathleen J. Pena, Elizabeth Moreno, Eric Griffis, Stephanie G. Labou, Alessandra Franco, Lori Broderick, Hal M. Source Type: research
More News: Academies | Allergy | Allergy & Immunology | Asthma | Biomedical Science | Cardiology | Children | Coronavirus | COVID-19 | Heart | Kawasaki Disease | Respiratory Medicine | SARS